Due to health issues, this site is no longer maintained and will be shut down shortly. |
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
$17.04 +0.14 (0.83%)
As of 03/27/2023 14:25:04 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.